Osmetech wins 510(k) for thrombophilia diagnostic; St. Jude increased revenue by cutting jobs;

> Osmetech won FDA 510(k) clearance for its eSensor diagnostic for thrombophilia, a hereditary condition involving a propensity to develop blood clots. Report

> Chinese medical devices producer Golden Meditech established a joint venture, Golden Meditech Information Management (China), with renowned U.S. government medical insurance management firms SynerMed and EHS, in Shanghai, the financial hub of China. Story

> St. Jude Medical, which last year chose to cut medical device jobs, has shared that its first quarter results reflect the benefit of its restructuring. The company reported net sales of $1.262 billion in the first quarter of 2010, an increase of 11 percent compared with the first quarter of 2009. Report

> Cardiovascular Systems, has received FDA unconditional investigational device exemption approval to proceed with ORBIT II, a pivotal trial to evaluate the safety and effectiveness of its Diamondback 360 System in the coronary arteries. Release

> With support from the EU Commission, GE Healthcare and a group of 10 medical device manufacturers within the European Coordination Committee of the Radiological, Electromedical and Healthcare IT industry have committed to a self-regulatory initiative to reduce the average energy consumption of new ultrasound products by 25 percent by 2012. Release

> The use of a mobile compression device for the prevention of thromboembolic disease after total hip arthroplasty is likely just as effective as low-molecular-weight heparin treatment but safer, according to a study in the March issue of the Journal of Bone & Joint SurgeryReport

> Congressman Erik Paulsen (R-MN), co-chair of the House Medical Technology Caucus, introduced a bill, the Defend Medical Innovation Act, to overturn a $20 billion excise tax on medical device companies included in the health reform bills. Item

And Finally... An occupational therapist is pioneering a new "virtual" method to analyze movement patterns in children--and more effectively treat those with debilitating motor disorders. Report